Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection
Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection have?
Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection has 74 citations in the OpenAlex counts ScholarIQ stores.
When was Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection published?
Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection has 2016 year in the ScholarIQ index.
What is the open-access status of Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection?
Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection has closed oa status in the ScholarIQ index.
What is the DOI of Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection?
The DOI for Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection is on the source record.
What is the PMID of Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection?
The PMID for Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection is on the source record.
What is the OpenAlex record for Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection?
The OpenAlex for Serum <scp>WFA</scp><sup>+</sup>‐M2<scp>BP</scp> levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection is on the source record.